Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset (Callithrix jacchus) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses-Reference-Cited by-同舟云学术

Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset (Callithrix jacchus) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses

Published:2001-09-01 Issue:5 Volume:167 Page:2942-2949
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Boon Louis,Brok Herbert P. M.,Bauer Jan,Ortiz-Buijsse Antonio,Schellekens Marc M.,Ramdien-Murli Seema,Blezer Erwin,van Meurs Marjan,Ceuppens Jan,de Boer Mark,’t Hart Bert A.,Laman Jon D.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. A central role of CD40 ligand in the regulation of CD4+ T-cell responses

2. Functions of CD40 on B cells, dendritic cells and other cells

3. CD40-CD40 ligand

4. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

5. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab;Xenobiotica;2024-07-26

2. Epitope Spreading in Autoimmune Diseases;Infection and Autoimmunity;2024

3. An Unexpected Symbiosis of Animal Welfare and Clinical Relevance in a Refined Nonhuman Primate Model of Human Autoimmune Disease;Nonhuman Primate Welfare;2023

4. CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells;The Journal of Immunology;2022-12-01

5. Animal Models of Multiple Sclerosis;Current Protocols;2021-06